To determine whether the in vivo tumor growth inhibitory effect of Lip-FLLL32 was connected to the reduction of STAT3 phosphorylation and transcriptional activity, one tumor from each group after one-week's treatment was removed to detect the expression of pSTAT3 and its target genes. This evidence concerns the gene STAT3 and neoplasm.